help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-124-1-24
Endocrinology Vol. 124, No. 1 24-29
Copyright © 1989 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by STRUTHERS, R. S.
Right arrow Articles by VALE, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by STRUTHERS, R. S.
Right arrow Articles by VALE, W.

Nucleotide Regulation of Growth Hormone-Releasing Factor Binding to Rat Pituitary Receptors*

R. SCOTT STRUTHERS{dagger}, MARILYN H. PERRIN and WYLIE VALE{ddagger}

The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute La Jolla, California 92037
Division of Phamacology, Department of Medicine, M-013H, University of California-San Diego (R.S.S.,W. Y.) La Jolla, California 92093

Address requests for reprints to: Dr. Wylie Vale, The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, 10010 North Torrey Pines Road, La Jolla, California 92037.

Abstract

The specific binding of a GRF radioligand, [His1,125I-Tyr10,Nle27]hGRF-l-32NH2, to rat pituitary homogenates is reduced by the addition of GTP and its nonhydrolyzable analogs 5'-guanylylimidodiphosphate (GppNHp) and guanosine 5'-O-(3-thiotriphosphate) (GTP-{gamma}-S). GDP and cAMP had no effect while the nonhydrolyzable ATP analogs 5'-adenylylimidodiphosphate and adenosine 5'-O-(3-thiotriphosphate) did elicit a significant reduction in GRF binding. The effect of GppNHp was half-maximal at 0.2 µM, and the maximum inhibition achieved was 85%. The effect of 0.1 µM GppNHp on GRF competitive displacement experiments indicated a significant reduction in affinity for the ligand (Kd = 0.51 ± 0.11 nM in the absence of GppNHp and 2.1 ± 1.1 nM in its presence) without an effect on receptor number. The GRF radioligand dissociates slowly from its receptor (t.{wedge} = 250 ± 50 min), but the addition of 0.1 fiU GppNHp converts approximately half of the receptors present to a more rapidly dissociating form (tA = 9 ± 10 min). These results are consistent with existing models for receptor- G-protein interactions, and thus, we conclude that transduction of the GRF response across the cell membrane involves a guanine nucleotide-binding protein, presumably G8. (Endocrinology 124: 24–29, 1989)

Footnotes

* This work was supported in part by NIH Grant DK-26741, Sanofi, and The Harry and Grace Steele Foundation, and was conducted in part by The Clayton Foundation for Research, California Division.

{dagger} Supported by the Paul Stock Foundation.

{ddagger} Clayton Foundation Senior Investigator.

Received July 11, 1988.




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
E. E. Muller, V. Locatelli, and D. Cocchi
Neuroendocrine Control of Growth Hormone Secretion
Physiol Rev, April 1, 1999; 79(2): 511 - 607.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society